• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.62 Down 0.05(2.99%) Feb 27, 4:07PM EST
    |After Hours : 1.63 Up 0.01 (0.31%) Feb 27, 4:32PM EST
    Add to Portfolio
    Prev Close:1.67
    Open:1.66
    Bid:1.62 x 21000
    Ask:1.63 x 6700
    1y Target Est:4.56
    Beta:1.27
    Next Earnings Date: 5-Mar-15NAVB Earnings announcement
    Day's Range:1.62 - 1.66
    52wk Range:0.97 - 2.12
    Volume:267,098
    Avg Vol (3m):1,024,450
    Market Cap:243.28M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 2.99%243.28M
    LLYUp 0.20%74.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):54.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.23
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback